Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's kidney cancer drug Welireg with its ...
Zacks Investment Research on MSN
Is it worth investing in Merck (MRK) based on Wall Street's bullish views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
The approvals are based on a Phase 3 study that showed the Keytruda-Welireg combo cut the risk of the cancer coming back, spreading or death by 28% compared with Keytruda plus pla ...
Merck & Co., Inc. (NYSE:MRK) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks. Reuters reported on ...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive ...
Merck & Co. says it will settle a spate of lawsuits that blame the drugmaker’s blockbuster Gardasil cancer vaccine for ...
Merck & Co. has agreed to buy agricultural-technology company Targan for an undisclosed amount in a deal that expands the drugmaker's animal-health business. Merck on Thursday said the acquisition, ...
More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions ...
Merck (NYSE:MRK) announced a partnership with The Hashgraph Group to build digital product traceability tools aligned with ...
Study results accrued so far are giving Merck greater conviction that the therapy, licensed from a China-based biotech, was worth placing into a sprawling Phase 3 program.
Merck reported first-quarter results that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products. The pharmaceutical giant also narrowed its 2026 sales ...
Gilead Sciences Inc. and Merck & Co. said an experimental long acting pill combining two HIV medicines had met its primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results